Prelude Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.3M Buy
25,016
+7
+0% +$364 0.13% 198
2025
Q1
$1.07M Sell
25,009
-17,191
-41% -$732K 0.08% 243
2024
Q4
$1.29M Buy
42,200
+24,100
+133% +$736K 0.08% 251
2024
Q3
$415K Sell
18,100
-1,613
-8% -$37K 0.03% 626
2024
Q2
$569K Sell
19,713
-4,103
-17% -$118K 0.04% 427
2024
Q1
$491K Buy
+23,816
New +$491K 0.03% 572
2023
Q4
Sell
-8,600
Closed -$255K 1071
2023
Q3
$255K Buy
+8,600
New +$255K 0.02% 641
2023
Q1
Sell
-9,967
Closed -$271K 1181
2022
Q4
$271K Sell
9,967
-4,739
-32% -$129K 0.01% 719
2022
Q3
$792K Sell
14,706
-1,237
-8% -$66.6K 0.03% 477
2022
Q2
$643K Buy
+15,943
New +$643K 0.02% 570
2022
Q1
Sell
-5,226
Closed -$523K 1663
2021
Q4
$523K Buy
5,226
+1,656
+46% +$166K 0.01% 752
2021
Q3
$446K Sell
3,570
-3,351
-48% -$419K 0.01% 709
2021
Q2
$860K Buy
6,921
+4,711
+213% +$585K 0.03% 540
2021
Q1
$337K Sell
2,210
-4,608
-68% -$703K 0.01% 742
2020
Q4
$879K Buy
6,818
+1,098
+19% +$142K 0.02% 232
2020
Q3
$639K Buy
5,720
+2,070
+57% +$231K 0.03% 236
2020
Q2
$296K Buy
3,650
+2,936
+411% +$238K 0.02% 411
2020
Q1
$50K Buy
+714
New +$50K ﹤0.01% 476
2019
Q4
Sell
-11
Closed -$1K 1538
2019
Q3
$1K Sell
11
-1,389
-99% -$126K ﹤0.01% 1127
2019
Q2
$121K Sell
1,400
-2,089
-60% -$181K 0.01% 590
2019
Q1
$268K Sell
3,489
-5,555
-61% -$427K 0.02% 377
2018
Q4
$340K Buy
+9,044
New +$340K 0.02% 382